Bajaj Consumer Care Ltd Valuation Shifts Signal Enhanced Price Attractiveness

Valuation Metrics Reflecting Improved Price Appeal

As of 21 Apr 2026, Bajaj Consumer Care’s price-to-earnings (P/E) ratio stands at 32.57, a figure that has contributed to its reclassification from an expensive to a fair valuation grade. This P/E multiple is notably lower than several FMCG peers such as Gillette India, which trades at a very expensive P/E of 41.28, and Hatsun Agro at 62.03. The company’s price-to-book value (P/BV) ratio is 8.21, which, while elevated, remains within a reasonable range given its sector and growth prospects.

Enterprise value to EBITDA (EV/EBITDA) ratio is another key valuation yardstick where Bajaj Consumer Care registers 26.28, slightly below Gillette India’s 28.06 and significantly lower than Honasa Consumer’s 57.78. This suggests that the company’s earnings before interest, taxes, depreciation and amortisation are being valued more conservatively compared to some of its more expensive peers.

Strong Financial Performance Underpins Valuation

Bajaj Consumer Care’s return on capital employed (ROCE) is an impressive 56.37%, indicating highly efficient use of capital to generate profits. Similarly, its return on equity (ROE) of 25.19% reflects strong shareholder returns. These metrics support the company’s current valuation and justify investor confidence despite the relatively high multiples.

The PEG ratio, which adjusts the P/E ratio for earnings growth, is a compelling 0.49, signalling that the stock is undervalued relative to its growth prospects. This contrasts sharply with Gillette India’s PEG of 1.34 and Hatsun Agro’s 1.66, underscoring Bajaj Consumer Care’s attractive valuation on a growth-adjusted basis.

Market Capitalisation and Price Movements

Classified as a small-cap stock, Bajaj Consumer Care’s market capitalisation reflects its niche positioning within the FMCG sector. The stock closed at ₹474.30 on 21 Apr 2026, up 0.82% from the previous close of ₹470.45. It touched a high of ₹497.05 during the day, matching its 52-week high, while the 52-week low was ₹153.00, illustrating a strong upward trajectory over the past year.

Outperformance Against Benchmarks

In terms of returns, Bajaj Consumer Care has significantly outpaced the Sensex across multiple timeframes. Year-to-date, the stock has surged 85.24%, while the Sensex has declined 7.86%. Over one year, the stock’s return is a remarkable 173.29%, compared to a flat Sensex performance. Even over three years, Bajaj Consumer Care’s 204.43% return dwarfs the Sensex’s 31.67% gain. This outperformance highlights the company’s strong operational execution and investor appeal.

Comparative Valuation Within FMCG Peers

When compared with its FMCG peers, Bajaj Consumer Care’s valuation appears more balanced. While companies like Bikaji Foods and Zydus Wellness trade at expensive multiples (P/E of 64.88 and 63.99 respectively), Bajaj Consumer Care’s P/E of 32.57 is more moderate. This fair valuation grade is supported by its strong profitability and growth metrics, making it a compelling option for investors seeking growth with reasonable price discipline.

Peers such as Emami and Godrej Agrovet also trade at fair to very attractive valuations, but Bajaj Consumer Care’s superior ROCE and PEG ratio provide it with a competitive edge. The company’s EV to capital employed ratio of 15.92 further indicates efficient capital utilisation relative to its enterprise value.

Historical Valuation Context

Historically, Bajaj Consumer Care’s valuation had been considered expensive, which may have limited its appeal to value-conscious investors. The recent shift to a fair valuation grade reflects a recalibration of market expectations, possibly driven by sustained earnings growth and improved operational efficiencies. This re-rating enhances the stock’s attractiveness, especially for investors looking to capitalise on quality FMCG businesses trading at reasonable multiples.

Risks and Considerations

Despite the positive valuation shift, investors should remain mindful of the stock’s relatively high P/BV ratio of 8.21, which suggests a premium on book value. Additionally, the absence of a dividend yield may deter income-focused investors. Market volatility and sector-specific risks, such as raw material price fluctuations and competitive pressures, also warrant consideration.

Outlook and Investment Implications

With a MarketsMOJO score of 84.0 and an upgraded mojo grade from Buy to Strong Buy as of 07 Apr 2026, Bajaj Consumer Care is positioned favourably for investors seeking growth in the FMCG sector. The company’s valuation reset to fair multiples, combined with strong profitability and market outperformance, suggests a compelling risk-reward profile.

Investors should monitor the company’s ability to sustain its high ROCE and ROE levels, as well as any changes in sector dynamics that could impact earnings growth. Given the stock’s recent price appreciation and valuation improvement, it may now offer a more attractive entry point compared to its historical premium pricing.

In summary, Bajaj Consumer Care Ltd’s valuation parameters have shifted positively, signalling enhanced price attractiveness relative to both its historical levels and peer group. This re-rating, supported by robust financial metrics and strong market returns, underpins the stock’s upgraded investment recommendation and positions it as a noteworthy contender in the FMCG space.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →